Cargando…
Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer
Rationale: Oxaliplatin is a widely used chemotherapy drug for advanced colorectal cancer (CRC) and its resistance is a major challenge for disease treatment. However, the molecular mechanism underlying oxaliplatin resistance remains largely elusive. Methods: An integrative analysis was performed to...
Autores principales: | Yu, Minhao, Wang, Hao, Zhao, Wei, Ge, Xiaoxiao, Huang, Wei, Lin, Fengjuan, Tang, Wenbo, Li, Ang, Liu, Sailiang, Li, Rong-Kun, Jiang, Shu-Heng, Xue, Junli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169372/ https://www.ncbi.nlm.nih.gov/pubmed/35673560 http://dx.doi.org/10.7150/thno.69863 |
Ejemplares similares
-
Type Iγ phosphatidylinositol phosphate kinase promotes tumor growth by facilitating Warburg effect in colorectal cancer
por: Peng, Wei, et al.
Publicado: (2019) -
EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression
por: Chen, Chunhua, et al.
Publicado: (2017) -
Silencing of type Iγ phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion
por: Cao, Siyu, et al.
Publicado: (2017) -
Silencing of type Iγ phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion
por: Cao, Siyu, et al.
Publicado: (2021) -
Targeting Type Iγ Phosphatidylinositol Phosphate Kinase Inhibits Breast Cancer Metastasis
por: Chen, Chunhua, et al.
Publicado: (2014)